热门资讯> 正文
美敦力赢得上诉，避免1.065亿美元的专利判决
2025-07-19 02:48
- A federal appeals court on Friday overturned a California federal jury verdict that ordered Medtronic (NYSE:MDT) to pay $106.5M to rival Colibri Heart Valve LLC in a patent infringement lawsuit related to heart valve replacement technology.
- A three-judge panel of the U.S. Court of Appeals for the Federal Circuit found that prior to the trial, the lower court judge had failed to determine if the Ireland-based MedTech giant had violated Colibri’s patent.
- In 2020, Colorado-based Colibri filed the lawsuit in the U.S. District Court alleging Evolut devices manufactured by Medtronic subsidiary CoreValve LLC infringed its patent related to self-expanding artificial heart valves.
- After a seven-day trial in 2023, a federal jury in Santa Ana, California, ordered Medtronic (NYSE:MDT) to pay $106.5M to Colibri for the alleged violation.
More on Medtronic plc
- Medtronic: Cash Flow Strength Balanced By Execution Risks
- Medtronic: Margin Inflection With Diabetes Spin - Key Drivers
- Medtronic: Eyes On The Pipeline And Spin, Shares Still Cheap
- Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again
- Texas Instruments plans to invest over $60B in US chip manufacturing
推荐文章
港股周报丨三家外卖平台被约谈！“疯狂星期六”或不再疯狂；花旗呼吁增持中国互联网、科技及消费板块
美股机会日报 | 特朗普放大招！9万亿养老金即将杀入加密市场；美联储主席候选人支持7月降息
一周财经日历 | 特斯拉、谷歌财报重磅来袭！维立志博将于下周五登陆港交所
一图看懂 | 港股上半年IPO募资额登顶全球！中签就赚一万港币的“大肉签”你参与了吗？
黄仁勋年内三度访华！H20重返中国市场，释放了什么信号？
创新药行情彻底爆发！维立志博-B打新半日孖展超购130倍，冻资近150亿港元
新股申购 | 维立志博-B入场费3535.30港元！引入腾讯、易方达等基石投资者
7月财报预告丨迎关税考验！特斯拉、台积电放榜在即，美股能否守住涨势？
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
